BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15679636)

  • 1. Rules of evidence: CMS and primary prevention of sudden cardiac death in systolic heart failure.
    Sweeney MO; Schoenfeld MH; Cannom DS
    Pacing Clin Electrophysiol; 2005 Feb; 28(2):81-8. PubMed ID: 15679636
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pathway for sudden cardiac death prevention.
    Herzog E; Aziz EF; Kukin M; Steinberg JS; Mittal S
    Crit Pathw Cardiol; 2009 Mar; 8(1):1-6. PubMed ID: 19258831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure therapy and sudden cardiac death prevention.
    Morgan JM
    Minerva Cardioangiol; 2004 Dec; 52(6):521-4. PubMed ID: 15729212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
    Groeneveld PW
    LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary prevention of sudden death - afraid of the truth].
    Klein H
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2113. PubMed ID: 12397556
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.
    Tung R; Swerdlow CD
    Circulation; 2009 Sep; 120(10):825-7. PubMed ID: 19704090
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrical treatment in heart failure].
    Leclercq C; Mabo P; Daubert C
    Rev Prat; 2010 Sep; 60(7):947-50. PubMed ID: 21033492
    [No Abstract]   [Full Text] [Related]  

  • 11. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.
    Al-Khatib SM; Sanders GD; Mark DB; Lee KL; Bardy GH; Bigger JT; Buxton AE; Connolly S; Kadish A; Moss A; Feldman AM; Ellenbogen KA; Singh S; Califf RM;
    Am Heart J; 2005 Jun; 149(6):1020-34. PubMed ID: 15976783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution and revolution of the implantable cardioverter defibrillator.
    Indik JH
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indication of implantable cardioverter defibrillator for heart failure].
    Noda T; Kamakura S
    Nihon Rinsho; 2007 May; 65 Suppl 5():195-9. PubMed ID: 17571384
    [No Abstract]   [Full Text] [Related]  

  • 14. ICD for primary prophylaxis of sudden cardiac death: an Indian perspective.
    Naik N; Juneja R
    J Assoc Physicians India; 2007 Apr; 55 Suppl():47-53. PubMed ID: 18376491
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Sudden death in heart failure: an ounce of prediction is worth a pound of prevention.
    Baliga RR; Young JB
    Heart Fail Clin; 2011 Apr; 7(2):xiii-xviii. PubMed ID: 21439492
    [No Abstract]   [Full Text] [Related]  

  • 16. Sudden death prophylaxis in heart failure.
    Rosanio S; Schwarz ER; Vitarelli A; Zarraga IG; Kunapuli S; Ware DL; Birnbaum Y; Tuero E; Uretsky BF
    Int J Cardiol; 2007 Jul; 119(3):291-6. PubMed ID: 17208319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Referring patients for consideration of device treatment of sudden cardiac death and heart failure: incorporating evidence-based therapies within the Canadian health care system.
    Gillis AM
    Can J Cardiol; 2005 May; 21 Suppl A():25A-30A. PubMed ID: 15953941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
    Botto GL; Proclemer A; Luzi M; Ruffa F; Gorgoglione MG; Ferrari G
    Ital Heart J; 2005 Mar; 6(3):210-5. PubMed ID: 15875511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention.
    Al-Khatib SM; Sanders GD; Carlson M; Cicic A; Curtis A; Fonarow GC; Groeneveld PW; Hayes D; Heidenreich P; Mark D; Peterson E; Prystowsky EN; Sager P; Salive ME; Thomas K; Yancy CW; Zareba W; Zipes D
    Am Heart J; 2008 Oct; 156(4):613-22. PubMed ID: 18926144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-wave alternans in the sudden cardiac death in heart failure trial population: signal or noise?
    Rosenbaum DS
    Circulation; 2008 Nov; 118(20):2015-8. PubMed ID: 19001031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.